Performance of Biodegradable Temporizing Matrix vs Collagen-chondroitin Silicone
Wu SS, Wells M, Ascha M, Gatherwright J, Chepla K. A multi center retrospective analysis for Plastic Surgery, Cleveland, OH, USA. Wounds. 2022.
- This is one of the few studies of BTM cases reported to date to directly compare wound healing and complication rates using NovoSorb BTM against Integra DRT (referred to as CCS bilayer graft).
- The authors analysed data for 97 adult patients (51 BTM and 46 Integra DRT) with a range of wound etiologies including: trauma, iatrogenic, compartment syndrome, skin cancer and osteomyelitis.
- Although a cost-effectiveness analysis was not performed, the reported costs at this institution for BTM were dramatically lower than for Integra DRT.
- They concluded: Compared with CCS bilayer graft, BTM has comparable closure rates, time to healing, and complication rates. Wounds managed with BTM required fewer secondary procedures, including skin grafting, and had significantly lower rates of graft failure than those treated with CCS. These findings support consideration of BTM as an alternative to CCS when dermal templates are indicated for soft tissue reconstruction.